Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

By using their in-house manufactured culture media, the company eventually hopes to develop safe and reliable new therapeutics based on stem-cell technologies. Stem-cell treatments Mesenchymal ...

Cell proliferation was assessed using (3 ... In summary, our findings indicate that mixed co-culture of BMSCs+ACCs can differentiate into functional cartilage-like tissues in an in vivo OA ...

Our goals are to pioneer the development of biomaterial systems for 3D cell culture to further fundamental ... expansion and differentiation of bone marrow derived mesenchymal stem cells for ...

We were the first lupus organization in the U.S. to support stromal cell research. In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over ...

For this trial, specific stem cells called mesenchymal precursor cells (MPCs) are obtained from healthy donors, isolated and expanded, and are available as off -the-shelf readily available therapy.